Denise Carter - Jan 27, 2025 Form SCHEDULE 13D/A Schedule Report for Quoin Pharmaceuticals Ltd. (QNRX)

Filing Manager: Carter Denise P.
Reporting Manager: Denise Carter
Security: Quoin Pharmaceuticals Ltd. Ordinary Shares, no par value per share (represented by American Depositary Shares)
Symbol: QNRX
Shares outstanding: 19.2M shares
Disclosed Ownership: 939K shares
Ownership: 4.9%
Form type: SCHEDULE 13D/A
Date filed: 1/28/2025, 04:43 PM
Date of event: Jan 27, 2025
Previous filing: Jan 2, 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Denise Carter	4.9%	939K	939K	0	/s/ Denise Carter	Denise Carter	0001958621